<?xml version='1.0' encoding='UTF-8'?><metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns="http://dublincore.org/documents/dcmi-terms/"><dcterms:title>Impact of Emergency Department Probiotic Treatment of Pediatric Gastroenteritis: Randomized Controlled Trial</dcterms:title><dcterms:identifier>https://doi.org/10.7939/DVN/10896</dcterms:identifier><dcterms:creator>Freedman, Stephen</dcterms:creator><dcterms:creator>Farion, Ken</dcterms:creator><dcterms:creator>Schuh, Suzanne</dcterms:creator><dcterms:creator>Gouin, Serge</dcterms:creator><dcterms:creator>Williamson-Urquhart, Sarah</dcterms:creator><dcterms:creator>Sherman, Philip</dcterms:creator><dcterms:creator>Willan, Andrew</dcterms:creator><dcterms:creator>Goeree, Ron</dcterms:creator><dcterms:creator>Johnson, David</dcterms:creator><dcterms:creator>Black, Karen</dcterms:creator><dcterms:creator>Schnadower, David</dcterms:creator><dcterms:creator>Gorelick, Marc</dcterms:creator><dcterms:publisher>UAL Dataverse</dcterms:publisher><dcterms:issued>2016-10-21</dcterms:issued><dcterms:modified>2017-05-26T20:58:07Z</dcterms:modified><dcterms:description>PROGUT is a randomized, placebo-controlled, double-blind, six-center, Canadian, emergency department trial to determine whether the administration of a probiotic agent (Lacidofil) will result in a significantly lower proportion of children developing moderate to severe disease over the subsequent 2 weeks and will not be associated with a significantly greater occurrence of side effects.</dcterms:description><dcterms:subject>Medicine, Health and Life Sciences</dcterms:subject><dcterms:subject>diarrhea</dcterms:subject><dcterms:subject>digestive system diseases</dcterms:subject><dcterms:subject>gastrointestinal diseases</dcterms:subject><dcterms:subject>emergency departments</dcterms:subject><dcterms:subject>probiotics</dcterms:subject><dcterms:subject>pediatrics</dcterms:subject><dcterms:subject>randomized controlled trial</dcterms:subject><dcterms:subject>gastroenteritis</dcterms:subject><dcterms:isReferencedBy>Freedman SB, et al. Impact of Emergency Department Probiotic Treatment of Pediatric Gastroenteritis: Study Protocol for the PROGUT (Probiotic Regimen for Outpatient Gastroenteritis Utility of Treatment) Randomized Controlled Trial. Trials 15 (2014):170., doi, 10.1186/1745-6215-15-170, https://www.ncbi.nlm.nih.gov/pubmed/24885220</dcterms:isReferencedBy><dcterms:date>2013</dcterms:date><dcterms:dateSubmitted>2016-09-29</dcterms:dateSubmitted><dcterms:temporal>2013-10</dcterms:temporal><dcterms:temporal>2017-07</dcterms:temporal><dcterms:temporal>2013-10</dcterms:temporal><dcterms:temporal>2017-06</dcterms:temporal><dcterms:type>Clinical data; Questionnaire data</dcterms:type><dcterms:source>Modified Vesikari Score</dcterms:source><dcterms:spatial>Alberta</dcterms:spatial><dcterms:spatial>Canada</dcterms:spatial><dcterms:spatial> Calgary</dcterms:spatial><dcterms:spatial>Canada</dcterms:spatial><dcterms:spatial>Quebec</dcterms:spatial><dcterms:spatial>Montreal</dcterms:spatial><dcterms:spatial>Ontario</dcterms:spatial><dcterms:spatial>Canada</dcterms:spatial><dcterms:spatial>Ottawa</dcterms:spatial><dcterms:spatial>Ontario</dcterms:spatial><dcterms:spatial>Canada</dcterms:spatial><dcterms:spatial>Toronto</dcterms:spatial><dcterms:license>NONE</dcterms:license></metadata>